GlassScriptPhysician profile
Leigh Ann Hatch
NPI 1174151666
$1,535.09
in general payments reported to CMS, 2019-2025
17 companies · $1,216 in 2025
The $1,216 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $319 · 2025: $1,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,416 · Education: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,415.80 |
| Education | $119.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $295.52 | 2024-2025 | |
| Genzyme Corporation | $234.17 | 2025 | |
| Novartis Pharmaceuticals Corporation | $147.66 | 2024-2025 | |
| Galderma Laboratories, L.P. | $144.15 | 2025 | Nemluvio, Aklief |
| Lilly USA, LLC | $104.96 | 2024-2025 | Ebglyss, Taltz |
| Sanofi-Aventis U.S. LLC | $99.99 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.41 | 2024 | |
| Sun Pharmaceutical Industries INC. | $71.24 | 2024-2025 | |
| Amgen INC. | $56.76 | 2025 | Otezla |
| Ucb, INC. | $51.14 | 2025 | Bimzelx |
| Organon LLC | $48.11 | 2025 | Hadlima, Vtama |
| Regeneron Healthcare Solutions, INC. | $46.58 | 2024-2025 | Dupixent, Libtayo |
| Paratek Pharmaceuticals, INC. | $35.59 | 2025 | Nuzyra |
| Organogenesis INC. | $28.75 | 2025 | Puraply Wound Matrix |
| Incyte Corporation | $28.28 | 2024 | Opzelura |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $27.50 | 2025 | Xolair |
| Biofrontera INC. | $16.28 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leigh Hatch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.